MOESM8 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 8: Figure S7. Forest plots of the association between YKL-40 and clinicopathological parameters. (a)tumor stage (III-IVvs.I-II, C-D vs. A-B or extended vs. limited). Experimental, stage(III-IV, C-D or extended); Control, (I-II, A-B or limited). (b)metastasis status(lymph node or liver metastasis vs. no metastasis). Experimental, lymph node or liver metastasis. Control, no metastasis

MOESM5 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 5: Figure S5. Sensitivity analysis for the pooled hazard ratios in all patients with gastrointestinal tumors. The analysis was conducted by estimating the average hazard ratio in the absence of each study

MOESM2 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 2: Figure S2. Sensitivity analysis for the pooled hazard ratios in overall survival in all patients. The analysis was conducted by estimating the average hazard ratio in the absence of each study

MOESM6 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 6: Figure S6. Forest plot showing the meta-analysis of hazard ratio estimates for DFS/PFS in all patients. DFS, disease-free survival; PFS, progression-free survival

MOESM4 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 4: Figure S4. Contour-enhanced funnel plot of the association between serum/plasma YKL-40 and overall survival in gastrointestinal tumors

MOESM3 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 3: Figure S3. Forest plot showing the meta-analysis of hazard ratio estimates for overall survival in (a) the “Caucasian countries” subgroup and the “Asian countries” subgroup and (b) the “surgery” subgroup and “other treatment methods” subgroup

MOESM7 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 7: Table S1. Results of meta-regression analyses exploring causes of heterogeneity with DFS/PFS in solid tumors

MOESM1 of Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies

Additional file 1: Figure S1. Forest plot showing the meta-analysis of hazard ratio estimates for overall survival in all patients after the trim-and-fill method was applied